$CVR
CHICAGO RIVET & MACHINE CO Stock $cvr

$cvr Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000119312523138314 Filed on May 08, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$8.051M	$8.730M	$9.198M
YoY Change	-10.78%	-5.09%	-1.15%
Cost Of Revenue	$8.380M	$8.252M	$7.341M
YoY Change	10.6%	12.41%	0.98%
Gross Profit	-$329.0K	$477.5K	$1.856M
YoY Change	-122.75%	-74.28%	-8.76%
Gross Profit Margin	-4.09%	5.47%	20.18%
Selling, General & Admin	$1.359M	$1.258M	$1.296M
YoY Change	7.56%	-2.93%	-4.88%
% of Gross Profit		263.39%	69.8%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$306.1K	$306.0K	$320.4K
YoY Change	-4.48%	-4.49%	-2.95%
% of Gross Profit		64.09%	17.26%
Operating Expenses	$1.359M	$1.258M	$1.296M
YoY Change	7.56%	-2.93%	-4.88%
Operating Profit	-$1.689M	-$780.2K	$560.6K
YoY Change	-1025.43%	-239.18%	-16.61%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net	$23.00K	$43.06K	$9.760K
YoY Change	84.73%	341.14%	-45.44%
Pretax Income	-$1.666M	-$737.1K	$570.3K
YoY Change	-954.53%	-229.25%	-17.36%
Income Tax	-$354.0K	-$154.0K	$123.0K
% Of Pretax Income			21.57%
Net Earnings	-$1.312M	-$583.1K	$447.3K
YoY Change	-952.16%	-230.36%	-17.18%
Net Earnings / Revenue	-16.29%	-6.68%	4.86%
Basic Earnings Per Share
Diluted Earnings Per Share	-$1.36	-$0.60	$463.0K
COMMON SHARES
Basic Shares Outstanding	966.1K shares	966.1K shares	966.1K shares
Diluted Shares Outstanding	966.1K shares	966.1K shares	966.1K shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$3.218M	$4.459M	$4.056M
YoY Change	-10.7%	9.92%	-33.13%
Cash & Equivalents	$1.524M	$2.266M	$1.315M
Short-Term Investments	$1.694M	$2.193M	$2.741M
Other Short-Term Assets	$422.0K	$420.2K	$384.2K
YoY Change	-0.66%	9.37%	-0.16%
Inventory	$9.423M	$9.999M	$9.613M
Prepaid Expenses
Receivables	$5.904M	$6.173M	$6.638M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$19.95M	$21.72M	$20.69M
YoY Change	-2.6%	4.98%	5.4%
LONG-TERM ASSETS
Property, Plant & Equipment	$12.01M	$11.97M	$12.27M
YoY Change	-0.29%	-2.48%	-5.01%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$12.01M	$11.97M	$12.27M
YoY Change	-0.29%	-2.48%	-5.01%
TOTAL ASSETS
Total Short-Term Assets	$19.95M	$21.72M	$20.69M
Total Long-Term Assets	$12.01M	$11.97M	$12.27M
Total Assets	$31.96M	$33.69M	$32.97M
YoY Change	-1.75%	2.2%	1.27%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.234M	$1.621M	$1.447M
YoY Change	14.76%	12.07%	27.44%
Accrued Expenses	$84.24K	$115.7K	$979.7K
YoY Change	-71.81%	-88.19%	-2.44%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$2.432M	$2.596M	$2.860M
YoY Change	-2.94%	-9.23%	12.61%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.432M	$2.596M	$2.860M
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$3.296M	$3.501M	$3.762M
YoY Change	-2.65%	-6.94%	6.88%
SHAREHOLDERS EQUITY
Retained Earnings	$31.00M	$32.53M
YoY Change	-1.52%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)	$3.922M	$3.922M
YoY Change	0.0%
Treasury Stock Shares
Shareholders Equity	$28.67M	$30.19M	$29.20M
YoY Change
Total Liabilities & Shareholders Equity	$31.96M	$33.69M	$32.97M
YoY Change	-1.75%	2.2%	1.27%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	-$1.312M	-$583.1K	$447.3K
YoY Change	-952.16%	-230.36%	-17.18%
Depreciation, Depletion And Amortization	$306.1K	$306.0K	$320.4K
YoY Change	-4.48%	-4.49%	-2.95%
Cash From Operating Activities	-$712.7K	-$1.651M	-$388.4K
YoY Change	378.21%	325.19%	-57.13%
INVESTING ACTIVITIES
Capital Expenditures	$346.8K	$413.4K	-$120.6K
YoY Change	-480.67%	-442.83%	3.55%
Acquisitions
YoY Change
Other Investing Activities	$530.5K	$498.0K	$0.00
YoY Change			-100.0%
Cash From Investing Activities	$183.7K	$84.58K	-$120.6K
YoY Change	-301.59%	-170.14%	-107.41%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-212.6K	-$212.5K	-212.6K
YoY Change	0.0%	0.0%	0.0%
NET CHANGE
Cash From Operating Activities	-712.7K	-$1.651M	-388.4K
Cash From Investing Activities	183.7K	$84.58K	-120.6K
Cash From Financing Activities	-212.6K	-$212.5K	-212.6K
Net Change In Cash	-741.6K	-$1.779M	-721.5K
YoY Change	63.81%	146.61%	-242.02%
FREE CASH FLOW
Cash From Operating Activities	-$712.7K	-$1.651M	-$388.4K
Capital Expenditures	$346.8K	$413.4K	-$120.6K
Free Cash Flow	-$1.060M	-$2.065M	-$267.8K
YoY Change	1729.26%	671.03%	-66.08%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Entity File Number EntityFileNumber	000-01227
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	IL
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	36-0904920
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	901 Frontenac Road
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Naperville
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	IL
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	60563
CY2023Q1	dei	City Area Code CityAreaCode	630
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	357-8500
CY2023Q1	dei	Security12b Title Security12bTitle	Common Stock, par value $1.00 per share
CY2023Q1	dei	Trading Symbol TradingSymbol	CVR
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	966132	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2265723	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4045101	usd
CY2023Q1	us-gaap	Certificates Of Deposit At Carrying Value CertificatesOfDepositAtCarryingValue	2193000	usd
CY2022Q4	us-gaap	Certificates Of Deposit At Carrying Value CertificatesOfDepositAtCarryingValue	2691000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	160000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	160000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	6173074	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4975137	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	9998952	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	9121230	usd
CY2023Q1	us-gaap	Prepaid Taxes PrepaidTaxes	672119	usd
CY2022Q4	us-gaap	Prepaid Taxes PrepaidTaxes	509119	usd
CY2023Q1	us-gaap	Other Assets Current OtherAssetsCurrent	420199	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	422747	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	21723067	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	21764334	usd
CY2023Q1	us-gaap	Land And Land Improvements LandAndLandImprovements	1510513	usd
CY2022Q4	us-gaap	Land And Land Improvements LandAndLandImprovements	1510513	usd
CY2023Q1	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	6758266	usd
CY2022Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	6758266	usd
CY2023Q1	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	37494180	usd
CY2022Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	37080762	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	45762959	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	45349541	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	33793779	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	33487748	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	11969180	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	11861793	usd
CY2023Q1	us-gaap	Assets Assets	33692247	usd
CY2022Q4	us-gaap	Assets Assets	33626127	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	1621403	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	697235	usd
CY2023Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	675078	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	462332	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	115734	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	327961	usd
CY2023Q1	us-gaap	Customer Advances And Deposits Current CustomerAdvancesAndDepositsCurrent	183836	usd
CY2022Q4	us-gaap	Customer Advances And Deposits Current CustomerAdvancesAndDepositsCurrent	203717	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	2596051	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1691245	usd
CY2023Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	905084	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	948084	usd
CY2023Q1	us-gaap	Liabilities Liabilities	3501135	usd
CY2022Q4	us-gaap	Liabilities Liabilities	2639329	usd
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	1.00
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	1.00
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	4000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	4000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1138096	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1138096	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	966132	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	966132	shares
CY2023Q1	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	1138096	usd
CY2022Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	1138096	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	447134	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	447134	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	32527980	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	33323666	usd
CY2023Q1	us-gaap	Treasury Stock Value TreasuryStockValue	3922098	usd
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	3922098	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	30191112	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	30986798	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	33692247	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	33626127	usd
CY2023Q1	us-gaap	Revenues Revenues	8729725	usd
CY2022Q1	us-gaap	Revenues Revenues	9197696	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	8252222	usd
CY2022Q1	us-gaap	Cost Of Revenue CostOfRevenue	7341474	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	477503	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	1856222	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1257695	usd
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1295664	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-780192	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	560558	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	43055	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	9755	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-737137	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	570313	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-154000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	123000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-583137	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	447313	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.60
CY2022Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.46
CY2023Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.60
CY2022Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.46
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	966132	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	966132	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	966132	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	966132	shares
CY2023Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.22
CY2022Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.22
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	30986798	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-583137	usd
CY2023Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.22
CY2023Q1	us-gaap	Dividends Dividends	212549	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	30191112	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	28969365	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	447313	usd
CY2022Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.22
CY2022Q1	us-gaap	Dividends Dividends	212549	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	29204129	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-583137	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	447313	usd
CY2023Q1	us-gaap	Depreciation Depreciation	306032	usd
CY2022Q1	us-gaap	Depreciation Depreciation	320424	usd
CY2023Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-43000	usd
CY2022Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-24000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1197937	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-990427	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-877722	usd
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1093460	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-160452	usd
CY2022Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-37522	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	924168	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	754192	usd
CY2023Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	212746	usd
CY2022Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	197065	usd
CY2023Q1	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-212227	usd
CY2022Q1	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	53411	usd
CY2023Q1	us-gaap	Increase Decrease In Customer Advances And Deposits IncreaseDecreaseInCustomerAdvancesAndDeposits	-19881	usd
CY2022Q1	us-gaap	Increase Decrease In Customer Advances And Deposits IncreaseDecreaseInCustomerAdvancesAndDeposits	-15390	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1651410	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-388394	usd
CY2023Q1	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	413419	usd
CY2022Q1	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	120594	usd
CY2023Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities	498000	usd
CY2022Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities	0	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	84581	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-120594	usd
CY2023Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	212549	usd
CY2022Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	212549	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-212549	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-212549	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-1779378	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-721537	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4045101	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2036954	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2265723	usd
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1315417	usd
CY2023Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font:10pt Arial;margin:0">2. The Company extends credit on the basis of terms that are customary within our markets to various companies doing business primarily in the automotive industry. The Company has a concentration of credit risk primarily within the automotive industry and in the Midwestern United States. The Company has established an allowance for accounts that may become uncollectible in the future. This estimated allowance is based in part on management's evaluation of the financial condition of the customer and historical experience. The Company monitors its accounts receivable and charges to expense an amount equal to its estimate of potential credit losses. The Company considers a number of factors in determining its estimates, including the length of time its trade accounts receivable are past due, the Company's previous loss history and the customer's current ability to pay its obligation. The Company also considers current economic conditions, the economic outlook and industry-specific factors in its evaluation. Accounts receivable balances are charged off against the allowance when it is determined that the receivable will not be recovered.</p>
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	8729725	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	9197696	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	8729725	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	9197696	usd
CY2023Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	4609907	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	4460071	usd
CY2023Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	3147846	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	2747427	usd
CY2023Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	2862199	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	2534732	usd
CY2023Q1	us-gaap	Inventory Gross InventoryGross	10619952	usd
CY2022Q4	us-gaap	Inventory Gross InventoryGross	9742230	usd
CY2023Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	621000	usd
CY2022Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	621000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	9998952	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	9121230	usd

Files In Submission

Name	View Source	Status
cvr-20230331_pre.xml	Edgar Link	unprocessable
cvr-20230331_lab.xml	Edgar Link	unprocessable
cvr-20230331_def.xml	Edgar Link	unprocessable
cvr-20230331_cal.xml	Edgar Link	unprocessable
0001193125-23-138314-index-headers.html	Edgar Link	pending
0001193125-23-138314-index.html	Edgar Link	pending
0001193125-23-138314.txt	Edgar Link	pending
0001193125-23-138314-xbrl.zip	Edgar Link	pending
cvr-20230331.xsd	Edgar Link	pending
d483910d10q.htm	Edgar Link	pending
d483910dex31.htm	Edgar Link	pending
d483910dex32.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
d483910d10q_htm.xml	Edgar Link	completed
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CVR
CHICAGO RIVET & MACHINE CO Stock $cvr

2023 Q2 Form 10-Q Financial Statement

#000119312523138314 Filed on May 08, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CVR CHICAGO RIVET & MACHINE CO Stock $cvr

2023 Q2 Form 10-Q Financial Statement

#000119312523138314 Filed on May 08, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CVR
CHICAGO RIVET & MACHINE CO Stock $cvr